Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NB-UVB phototherapy plus fluticasone propionate vs NB-UVB plus placebo in active vitiligo
2008-006903-22Phase 4Active
- Sponsor
- Academic Medical Center
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Vitiligo comparing NB-UVB plus fluticasone propionate (Cutivate) with NB-UVB plus placebo (2 arms). Primary endpoint: Primary efficacy of NB-UVB plus fluticasone propionate vs NB-UVB alone. Started Dec 2008; status: active.
02
Drugs
fluticasone propionate
03
Conditions
Vitiligo
Beyond the preview
Go deeper on 2008-006903-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006903-22.